Location:
Hilton Montréal Bonaventure
900, de La Gauchetière West
Montréal (Québec) Canada
General Information
 Conference objectives
Accreditation and certification
Target audience
Topics
Language Policy
Important dates
Conference Secretariat
Conference objectives
This conference is designed to provide participants with the newest developments in the prevention, detection, diagnosis and treatment of beryllium sensitization and Chronic Beryllium Disease (CBC). The course will focus on medical surveillance and discuss the immunologic bases of the Beryllium Lymphocyte Proliferation (LPT) Test. The latest research on exposure, epidemiology, and clinical care as well as an international overview of beryllium sensitization and chronic beryllium disease will be presented by participants.
Accreditation and certification
Accreditation Council for Continuing Medical Education (ACCME)
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). National Jewish Medical and Research Center is accredited by the ACCME to sponsor continuing medical education for physicians and takes responsibility for the content, quality, and scientific integrity of this CME activity. National Jewish designates this educational activity for a maximum of 21 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.American Board of Industrial Hygiene (ABIH)
Certification maintenance points through the American Board of Industrial Hygiene will be provided for Industrial Hygienists.
Registration Maintenance Committee of the Canadian Registration Board
The Registration Maintenance Committee of the Canadian Registration Board of Occupational Hygienists will award 1.0 point for each full day and 0.5 point for each 1/2 day of Conference. For information : 
Target audience
- Epidemiologists
- Geneticists
- Health and Safety professionals
- Immunologists
- Industrial Hygienists
- Physicians, nurses
- Researchers
Topics
- Overview of Beryllium Uses, Health Effects, Exposure, and Surveillance
- Methods for Diagnosing Beryllium Sensitization and CBD
- Epidemiology of Beryllium Sensitization and CBD
- Current Clinical Cases
- Industrial Medical Surveillance Programs
- International Overview of Beryllium Disease and Exposure Assessment
- Industrial Hygiene Update
- Molecular, and Genetic Mechanisms of Chronic Beryllium Disease and Beryllium Sensitization
- New Approaches to Medical Surveillance Testing
Language Policy
The official languages of the Conference are English and French. Simultaneous interpretation will be provided.
Important dates
December 15, 2004
|
Last day for pre-registration at preferred rates |
| February 5, 2005 |
Deadline for the preferential rate for reserving a room
at the Hilton Montréal Bonaventure Hotel |
Conference Secretariat
Adress all correspondence to the Conference secretariat
IRSST
Beryllium 2005 Conference
505, boul. De Maisonneuve Ouest, 15e étage
Montréal (Québec)
Canada
H3A 3C2
Phone: 1 (514) 288-1551
Fax: 1 (514) 288-7636
Beryllium2005@irsst.qc.ca
http://www.irsst.qc.ca/en/home.html
| |
